Application of medication composition of containing corydalis tuber in preparing medication for treating chronic insufficiency of supplying blood for brain

A technology of insufficient cerebral blood supply and composition, applied in the field of medicine, can solve the problems of lack of focal neurological signs in the brain and the need for further research on long-term efficacy

Inactive Publication Date: 2006-12-06
TIANJIN TASLY PHARMA CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0033] 3. No focal neurological signs of the brain
[0043] 3. No focal neurological signs of the brain;
[0044] 4. CT\MRI without vascular organic brain changes;
[0056] At present, the drugs used clinically to treat CCCI include: THA: c

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0087] Take medicinal materials according to the following weights: Corydalis Corydalis (made from vinegar) 500g, Beiliu Jinu 1500g, Rhizoma Drynariae 1500g, Ginseng 1000g;

[0088] Take the medicinal materials according to the above ratio, add water to extract 3 times, each time for 1 hour, combine the extracts, concentrate appropriately, add 2 times the amount of ethanol, let it stand for 24 hours to precipitate, take the supernatant and concentrate it into an extract, the relative density is 1.3~ 1.4, the paste yield is 10%, take clear paste, spray dry into powder.

[0089] Pass the above-mentioned powder, lactose, pregelatinized starch, and croscarmellose sodium through a 65-mesh sieve for later use, mix them with other auxiliary materials according to the equal-volume incremental method, and pass through a 65-mesh sieve 3 times; measure the angle of repose, and it is less than 30 °; measure the content, set the amount; pack the powder into No. 3 capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An application of the medicinal composition composed of corydalis tube, northern siphonostegia, fortume's drynaria rhizome and ginseng in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a medicinal composition containing Corydalis Corydalis in the preparation of a medicine for treating chronic cerebral insufficiency. Background technique [0002] The origin of the concept [0003] Chronic Cerebral Circulation Inefficiency (CCCI) refers to the state of reduced blood supply to the brain at the overall level (less than 40-60ml / 100g brain tissue / minute), rather than focal cerebral ischemia. It is a relatively new disease name proposed by foreign countries in the first 10 years. Clinically, some elderly or pre-senile patients who repeatedly complain of subjective symptoms such as heavy head and dizziness have neither focal signs of nerve damage nor brain CT abnormalities except fundus arteriosclerosis. Arteriosclerosis". It is well known that the concept and clinical diagnostic criteria of cerebral arterioscler...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/66A61P9/10A61P9/02
Inventor 范立君郑永锋
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap